- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Generex Biotechnology Corp+ Add to Watchlist
GNBT:US0.0230 USD 0.0010 4.55%
As of 20:10:00 ET on 07/21/2014.
Company Profile for Generex Biotechnology Corp (GNBT)
Generex Biotechnology Corporation researches and develops drug delivery systems and technology. The Company's initial product is an insulin formulation that is administered as a fine spray into the oral cavity using a hand held aerosol applicator. Generex is conducting clinical trials of its product in the United States, Canada, England, and Italy.
Generex Biotechnology Corp
Key Executives for Generex Biotechnology Corp (GNBT)
|Mark A FletcherPresident/Exec VP/CEO||Stephen FellowsChief Financial Officer|
|David A BrusegardCOO/Secretary||Eric Von HofeVice President|
|Todd FallsInvestor Relations|